Transcranial Magnetic Stimulators Market Analysis | Europe | 2017-2023 | MedCore

Transcranial Magnetic Stimulators Market Analysis | Europe | 2017-2023 | MedCore

0

Transcranial magnetic stimulators (TMS) are a non-invasive method of brain stimulation that utilizes electromagnetic induction to conduct research and deliver therapeutic treatment.
The medical device contains an insulated coil which generates brief magnetic pulses that pass painlessly through the skull and into the brain. When used for therapeutic means, these pulses are repeated multiple times to produce longer lasting changes. These pulses are delivered approximately once per second for thirty minutes to an hour multiple times a week. While one pulse per second is often used, devices are capable of reaching higher rates. This treatment is generally referred to as repetitive transcranial magnetic stimulation (rTMS) and it has been tested as a means to treat a variety of neurological and psychiatric disorders.

  • Year: 2017
  • Scope: 2013-2023
  • Region: Europe
  • Published Date: 12/1/2016
  • Pages: 252
  • Type: MedCore

The largest market is currently Germany with larger markets in France, United Kingdom and Italy as well. These areas have higher populations and also conduct more research. The replacement rate is only 15% in 2016 with the majority of sales being new units placed. Most systems will last between eight to twelve years; however, some are known to last up to 20 years (typically for research application systems). Diagnostic and therapeutic application systems will last typically for five to seven years.

Transcranial magnetic stimulators (TMS) are a non-invasive method of brain stimulation that utilizes electromagnetic induction to conduct research and deliver therapeutic treatment. The medical device contains an insulated coil which generates brief magnetic pulses that pass painlessly through the skull and into the brain. When used for therapeutic means, these pulses are repeated multiple times to produce longer lasting changes. These pulses are delivered approximately once per second for thirty minutes to an hour multiple times a week. While one pulse per second is often used, devices are capable of reaching higher rates. This treatment is generally referred to as repetitive transcranial magnetic stimulation (rTMS) and it has been tested as a means to treat a variety of neurological and psychiatric disorders.

Segments Covered in This Market

  • Transcranial Magnetic Stimulator Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

Of the many companies in the European Transcranial Magnetic Stimulator market, Magstim was the leader, followed by MagVenture and MAG & More. Magstim’s TMS product lines include the Rapid² ™, which is a single-pulse and repetitive stimulator with high-frequency capabilities, the Standard Rapid² ™ Super Rapid² ™ and the Super Rapid² ™ Plus1, which is intended for applications such as theta burst, where a higher power/frequency relationship is required. Other companies analyzed include Neurosoft, Brainsway, and Nexstim.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled Europe Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices – MedSuite

Learn More about these product types



The "Europe Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Medtronic
Stryker
Codman & Shurtleff, Inc.
St. Jude Medical
Nevro
Carl Zeiss
Boston Scientific
LivaNova
Terumo MicroVention
Penumbra Inc.
Leica
Integra LifeSciences
BrainLab
Balt
Magstim
Phenox
MagVenture
Elekta
Moëller Wedel
Misonix
Sophysa
Aesculap
MAG & More
Neurosoft
Acandis
Soring
Brainsway
Nexstim
Others include: ANT, Asahi Intecc, Axonics, Blockade, Dispomedica, Enteromedics, Flowonix, Inomed, Intrapace, Kaneka Medical Products, MHT, Micrus Endovascular, MRC, Navimetric, Neuravi, Neuronetics, Neuropace, NextGen Medicla System, Nuvectra, Scientia Vascular, Spiegelberg, Stimwave, Tokai Medical Product, Tricumed, Vascular Solutions, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link
close-link